Cargando…

Convalescent-anti-SARS-CoV-2-plasma: Transfusion acute circulatory overload: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256968/ http://dx.doi.org/10.1007/s40278-021-98270-3

Ejemplares similares

Convalescent-anti-sars-cov-2-plasma: Transfusion-related acute lung injury and transfusion-associated circulatory overload: 3 case reports
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma: Anaphylactic shock and transfusion reaction: case report
Publicado: (2020)

Transfusion associated circulatory overload
por: Agnihotri, Naveen, et al.
Publicado: (2014)

Convalescent-anti-SARS-CoV-2-plasma: Transfusion reaction during off-label therapy: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Transfusion-related acute lung injury following off-label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Ecchymosis: case report
Publicado: (2022)

Immune-globulin: Transfusion associated circulatory overload: case report
Publicado: (2022)

Convalescent anti-SARS-CoV-2 plasma: Organising pneumonia: case report
Publicado: (2020)

Comment on: “Transfusion associated circulatory overload”
por: Ho, James K. H., et al.
Publicado: (2014)

Educational Case: Transfusion reactions: Transfusion associated circulatory overload vs transfusion-related acute lung injury
por: Desai, Diana S., et al.
Publicado: (2022)

Convalescent-anti-SARS-COV-2-plasma: Transfusion-related acute lung injury induced acute respiratory distress syndrome: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Necrotising myopathy and concurrent thyroiditis: case report
Publicado: (2021)

Convalescent-anti-sars-cov-2-plasma: Transfusion-related acute lung injury following off-label use: 2 case reports
Publicado: (2022)

559. Outcomes of Convalescent Plasma Transfusion for SARS-CoV2 Patients in the Intensive Care Unit
por: Khalid, Rabeeya, et al.
Publicado: (2020)

Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2021)

Post-partum sequential occurrence of two diverse transfusion reactions (transfusion associated circulatory overload and transfusion related acute lung injury)
por: Haldar, Rudrashish, et al.
Publicado: (2013)

Anakinra/convalescent-anti-SARS-CoV-2-plasma/prednisolone: Aggravation of SARS-CoV-2 hepatitis, SARS-CoV-2 viraemia and off-label use: case report
Publicado: (2021)

Chronicle of Hypoxemia: Transfusion-Associated Circulatory Overload Versus Transfusion-Related Acute Lung Injury
por: Jha, Shikha, et al.
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma/immunosuppressants: SARS-CoV-2 infection, its re-infection and off label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2022)

Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2022)

Convalescent anti SARS-CoV-2 plasma/norepinephrine/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2021)

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/remdesivir: Treatment failure and off-label use: case report
Publicado: (2021)

Blinatumomab/convalescent-anti-SARS-CoV-2-plasma: B-cell depletion and off label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Antivirals/convalescent-anti-SARS-CoV-2-plasma/imatinib: Haematological disorder and off label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Febrile TACO reaction following off-label use: case report
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma/heparin: Lack of efficacy following an off-label treatment: case report
Publicado: (2022)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection
por: Shoham, Shmuel, et al.
Publicado: (2021)

Anakinra\Convalescent-anti-SARS-CoV-2-plasma\dexamethasone: Pulmonary Aspergillosis and off label use: 6 case reports
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/enoxaparin-sodium/methylprednisolone: Various toxicities and off label use: case report
Publicado: (2021)

Remdesivir/methylprednisolone/convalescent-anti-SARS-CoV-2-plasma: Elevated aminotransferase levels and off-label use: case report
Publicado: (2021)

Azithromycin/convalescent-anti-SARS-CoV-2-plasma/steroids: Necrotising pancreatitis following off label use: case report
Publicado: (2022)

Transfusion‐associated circulatory overload—a systematic review of diagnostic biomarkers
por: Klanderman, Robert B., et al.
Publicado: (2018)

Series of errors leading to life-threatening transfusion-associated circulatory overload
por: Czempik, Piotr F., et al.
Publicado: (2023)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nbdfnp54cgnf0jgefltn0hkgj9